# Transfer Pricing: Arm's Length Principle, Methods and Disputes

> How the arm's length principle prices controlled transactions between associated enterprises — delineation, the five OECD methods, loans, IP/DEMPE, services, and the APA/MAP route when two states disagree.

Canonical: https://wiki.private.law/en/transfer-pricing
Topics: investments
Jurisdictions: global, uk, usa
Semantic tags: wealth-planning

---

## Concept

Transfer pricing answers one question: when two companies under common control trade with each other — money, goods, IP, services, guarantees — did they price the deal the way independent parties would have priced it? If not, the tax authority of the disadvantaged state recalculates the taxable profit *as if* the arm's length price had been charged. The contract stays valid, the cash flows stay where they went; only the tax base moves.

> 💡 Short answer: every priced transaction between associated enterprises is tested against the *arm's length principle* — the condition independent enterprises would have agreed in comparable circumstances (Article 9 of the OECD Model Convention). The test runs on facts, not labels: what functions each party actually performs, what assets it uses, what risks it genuinely controls. A price is defended by a method applied to real comparables, not by the group's own approval of it. And passing the price test settles only the price — deductibility, withholding, beneficial ownership and substance are separate examinations with separate outcomes.

The rule exists because a group can set any internal price it likes. An operating company paying 9% interest to a group lender instead of 5% moves four points of profit, every year, from its own tax base to the lender's — without any external event. States respond not by policing the group's motives but by imposing a benchmark: the [OECD Transfer Pricing Guidelines](https://www.oecd.org/content/dam/oecd/en/publications/reports/2022/01/oecd-transfer-pricing-guidelines-for-multinational-enterprises-and-tax-administrations-2022_57104b3a/0e655865-en.pdf) (2022 edition, published 20 January 2022) elaborate how the arm's length condition of Article 9 is found, and domestic law gives it teeth — in the UK through [TIOPA 2010 Part 4](https://www.legislation.gov.uk/ukpga/2010/8/section/147), which must be read consistently with the OECD Guidelines ([s.164](https://www.legislation.gov.uk/ukpga/2010/8/section/164)), in the US through [IRC §482](https://www.govinfo.gov/link/uscode/26/482) and its regulations, which run a parallel system with the same logic.

One example shows the whole machine. A parent lends its foreign subsidiary 10,000,000 at 9% (the numbers here and throughout are fictional teaching inputs). The subsidiary's state asks: delineate the actual transaction — is this really a loan of that size, on those terms, to this borrower? Then: what would an independent lender have charged this borrower, with its actual credit standing *including* the comfort of belonging to the group? If the evidence supports 5%, the subsidiary's deduction is cut to 5% on the tested amount; the excess four points are taxed. Whether the lender's state then reduces its own tax on the interest it already taxed at 9% is a second, separate question — a corresponding adjustment under Article 9(2) that arrives through agreement between the two authorities, not automatically. Until it arrives, the same four points are taxed twice.

Three features of this test are routinely misread. First, it is bilateral in design but unilateral in operation: each state adjusts in its own favour, and the UK version is explicitly a one-way street — [s.147 TIOPA 2010](https://www.legislation.gov.uk/ukpga/2010/8/section/147) recalculates profits only where the actual provision confers "a potential advantage in relation to United Kingdom taxation," never in the taxpayer's favour. Second, it is indifferent to intent: no avoidance motive is required, and a fully commercial group with sloppy pricing is adjusted exactly like an aggressive one. Third, it is evidence-hungry in a specific way: the decisive material is not the invoice or the board resolution but the record of who did what — which people performed the functions, which entity had the capacity to control the risk, what an independent party in that position had available as alternatives.

---

## The Controlled Transaction: Delineation Before Pricing

The unit of analysis is the **controlled transaction** — a transaction between two *associated enterprises*: enterprises where one participates directly or indirectly in the management, control or capital of the other, or the same persons participate in both (Article 9(1) of the OECD Model; the UK equivalent is the "participation condition" in Part 4, the US trigger is two or more organisations "owned or controlled directly or indirectly by the same interests" under §482).

Before any price is tested, the transaction must be **accurately delineated**: what was actually agreed and actually done. The OECD Guidelines (Chapter I, Section D) direct the analysis to five comparability factors — the contractual terms; the functions performed, assets used and risks assumed by each party (the **FAR analysis**, in US regulatory language the comparability factors of [Treas. Reg. §1.482-1(d)](https://www.ecfr.gov/current/title-26/section-1.482-1)); the characteristics of the property or services; the economic circumstances of the parties and the market; and the parties' business strategies. Where the parties' conduct diverges from the contract, conduct controls: a contract that assigns market risk to a subsidiary that has no people, no information and no financial capacity to bear it does not move the risk for tax purposes.

Risk allocation follows a specific discipline. A risk belongs, for pricing purposes, to the party that **controls** it — that has the capability and actually exercises the decision-making to take on, decline and manage the risk — and has the **financial capacity** to bear it. A contractual risk-bearer that neither decides nor could absorb the loss is stripped of the risk and of the return that was supposed to compensate it. This single rule decides most modern IP and financing disputes before any benchmark is opened.

> 🍓 Delineation can also change the object being priced, not just the price. In exceptional cases a transaction that makes no commercial sense between independent parties can be disregarded or replaced for tax purposes; short of that, a purported loan can be examined on quantum as well as rate — whether an independent lender would have advanced that amount to that borrower at all — with the excess treated under the applicable domestic rules rather than priced as debt.

## The Arm's Length Standard in Three Systems

The concept is one; the machinery differs by state. The table compares the framework layer and two contrasting domestic regimes on the same axes, because a group facing an audit deals with a specific statute, not with the OECD.

| Axis | OECD framework | United Kingdom | United States |
| --- | --- | --- | --- |
| **Legal source** | Article 9 of the Model Convention; TP Guidelines 2022 as interpretive elaboration | [TIOPA 2010 Part 4](https://www.legislation.gov.uk/ukpga/2010/8/section/147); read consistently with the OECD Guidelines per [s.164](https://www.legislation.gov.uk/ukpga/2010/8/section/164) | [IRC §482](https://www.govinfo.gov/link/uscode/26/482) and Treas. Reg. §1.482-1 through -9 |
| **Direction of adjustment** | Either state may adjust upward under Art. 9(1) | One-way: only where the actual provision creates a potential UK tax advantage | The Secretary allocates income and deductions to "clearly reflect income" — a government power, with limited taxpayer self-adjustment |
| **Method selection** | "Most appropriate method" for the circumstances; five recognised methods | Follows OECD via s.164 | **Best method rule** ([§1.482-1(c)](https://www.ecfr.gov/current/title-26/section-1.482-1)): the method producing the most reliable measure, no fixed hierarchy |
| **Range concept** | Arm's length range of comparable outcomes | OECD range concept via s.164 | Interquartile range (§1.482-1(e)); adjustment typically to the median |
| **Intangibles specialty** | DEMPE functional analysis (Chapter VI) | OECD DEMPE via s.164 | "Commensurate with income" standard: intangible income must track the income the intangible actually produces; aggregate and realistic-alternative valuation |
| **Documentation** | Master file / local file model (Chapter V) | Mandatory master file and local file for groups at the €750m CbC threshold, periods from 1 April 2023 ([Transfer Pricing Records Regulations 2023, SI 2023/818](https://www.legislation.gov.uk/uksi/2023/818/contents/made)) | Contemporaneous documentation as penalty protection under [§6662(e)](https://www.govinfo.gov/link/uscode/26/6662) |
| **Penalty exposure** | — | Tax-geared penalties; rebuttable presumption of carelessness without required records | 20% penalty for substantial valuation misstatement (net §482 adjustment above the lesser of $5,000,000 or 10% of gross receipts); 40% for gross misstatement ($20,000,000 / 20%); a separate transactional penalty applies where the claimed price is 200% or more, or 50% or less, of the correct §482 price — 400% / 25% for the gross tier ([§1.6662-6](https://www.ecfr.gov/current/title-26/section-1.6662-6)) |
| **Who is outside the regime** | — | Small and medium-sized enterprises are exempt ([s.166 TIOPA 2010](https://www.legislation.gov.uk/ukpga/2010/8/section/166)), sized by reference to the Annex to Commission Recommendation 2003/361/EC ([s.172](https://www.legislation.gov.uk/ukpga/2010/8/section/172)) — unless the company elects out irrevocably or the counterparty is resident in a non-qualifying territory ([s.167](https://www.legislation.gov.uk/ukpga/2010/8/section/167)), or HMRC serves a transfer pricing notice on a medium-sized enterprise ([s.168](https://www.legislation.gov.uk/ukpga/2010/8/section/168)) | No size exemption: §482 reaches any two or more organisations under common control |

The practical consequence of the comparison: the same intercompany agreement is tested twice, under two statutes, by two authorities with opposite financial interests — which is why the pricing file has to work in both directions, not just for the state where the deduction sits.

Both statutes move, and the UK one has just moved a long way. [Finance Act 2026](https://www.legislation.gov.uk/ukpga/2026/11/contents) rewrites the architecture in four places: section 47 with Schedule 6 extends the participation condition to arrangements for common management and adds a UK-to-UK exemption where a domestic provision carries no risk of tax loss; section 46 repeals Diverted Profits Tax as a separate tax and re-charges the same ground inside corporation tax as *unassessed transfer pricing profits*, for accounting periods beginning on or after 1 January 2026 ([HMRC INTM489310](https://www.gov.uk/hmrc-internal-manuals/international-manual/intm489310)); section 48 introduces an International Controlled Transactions Schedule filed with the return, for accounting periods beginning on or after 1 January 2027, above £1,000,000 of aggregated cross-border related-party transactions with a £100,000 category threshold; and section 49 with Schedule 7 aligns the domestic permanent establishment rules with Articles 5 and 7 of the 2017 OECD Model. The [summary of responses of 26 November 2025](https://www.gov.uk/government/consultations/transfer-pricing-scope-and-documentation/outcome/transfer-pricing-scope-and-documentation-summary-of-responses) also records what did not change: medium-sized enterprises keep the exemption.

## Method and Comparability: How "the Market Price" Is Actually Found

"Market price" in transfer pricing is not a number pulled from intuition; it is the output of a method applied to comparables. The OECD recognises five methods — three transactional (comparable uncontrolled price, resale price, cost plus) and two profit-based (transactional net margin method, profit split) — and requires the **most appropriate** one for the delineated transaction; the US best method rule reaches the same place by asking which method yields the most reliable measure given comparability and data quality.

| Method | What it compares | Where it fits | Weakness |
| --- | --- | --- | --- |
| **CUP** | The price itself against identical or closely similar uncontrolled transactions | Commodities, listed-rate financing, licensed IP with genuine external licences | Extremely sensitive to product and term differences |
| **Resale price** | Gross margin of a reseller | Distribution without value-adding transformation | Accounting comparability of gross margins |
| **Cost plus** | Mark-up on the supplier's costs | Contract manufacturing, routine services | Cost base definition drives the result |
| **TNMM** | Net operating margin of the *tested party* against a set of independent companies | The workhorse where one party is routine and the other complex | Requires choosing the right tested party and profit level indicator |
| **Profit split** | Division of combined profit by each party's contribution | Both parties make unique, valuable contributions; highly integrated operations | Contribution measurement is contestable |

Two consequences follow from the table. The method is chosen by the delineation, not by convenience: a distributor that in fact develops local marketing intangibles has outgrown the resale price method whatever its contract says. And the output of any method is a **range**, established by an actual comparables search with stated screening criteria — geography, independence, functional profile, loss-makers in or out. A specific percentage or interquartile band belongs in a benchmarking study with its search documented; this article deliberately quotes none, because a range asserted without its search is exactly the kind of evidence that fails an audit.

> ⚙️ Timing discipline: comparability is assessed as of the transaction, on information reasonably available then. A study for a 2022 loan cannot be built on 2025 market data, and an annual refresh of the comparables set is standard practice for continuing transactions under both the OECD documentation model and the US contemporaneous-documentation penalty defence.

A newer shortcut narrows the benchmarking burden at the routine end of the distribution chain. The Inclusive Framework's [Pillar One – Amount B report](https://www.oecd.org/en/publications/2024/02/pillar-one-amount-b_41a41e1e.html) of 19 February 2024 sets out a *simplified and streamlined approach* to applying the arm's length principle to in-country baseline marketing and distribution activities, and its content has been incorporated into the Guidelines; a consolidated report of 23 February 2025 added a model competent authority agreement for treaty partners that apply it. How far it reaches depends on the state: the US made it elective, and [Notice 2025-4](https://www.irs.gov/pub/irs-drop/n-25-04.pdf) lets taxpayers rely on the approach for taxable years beginning on or after 1 January 2025, pending proposed regulations. A simplified result is an arm's length result only for a transaction actually in scope; nothing in the approach displaces delineation.

## Documentation: What Must Exist, and When

Documentation does not prove a price. It decides who has to explain, and it decides the penalty. The Guidelines' three-tier model (Chapter V) separates the **master file** — the group's global blueprint: structure, intangibles, intercompany financing, overall pricing policy — from the **local file**, which carries the entity's own controlled transactions, the method chosen for each and the comparables behind it, and from the **country-by-country report**, which sets out revenue, profit, tax and headcount by jurisdiction at the €750m threshold and is a risk-assessment input, never a pricing conclusion.

These are dated statutory duties, not good practice. In the UK master file and local file are mandatory for a UK member of an MNE group meeting the country-by-country threshold, for corporation tax accounting periods beginning on or after 1 April 2023 and for income tax from 2024–25; an entity with no material controlled transactions, or with only transactions covered by the UK-to-UK or APA exemption, falls outside the requirement, and an information notice for the specified records cannot be appealed ([HMRC INTM450010](https://www.gov.uk/hmrc-internal-manuals/international-manual/intm450010)). In the US the documentation is not filed at all, but it must be in existence **when the return is filed** and be supplied within 30 days of an examination request — that, and only that, defeats the net-adjustment penalty ([Treas. Reg. §1.6662-6(d)(2)(iii)](https://www.ecfr.gov/current/title-26/section-1.6662-6)).

Three different things therefore run on the same file, and groups routinely collapse them: the substantive rule (was the amount arm's length), the documentation duty (does the required record exist, on time, in the required form), and the penalty defence (does that record excuse being wrong). Failing the first with the second intact costs tax and interest; failing both adds a percentage on top.

## Pricing Is One Test Among Several

An arm's length price makes the transaction *correctly priced*. It does not make the payment deductible, treaty-relieved or respected for every other purpose — each of those is a separate test on separate facts, and clearing one clears none of the others.

| Test | Question it asks | Independent of pricing because… |
| --- | --- | --- |
| **Transfer pricing** | Is the amount what independent parties would have agreed? | — |
| **Deductibility** | Does the payer's domestic law allow this expense at all — interest-limitation caps, purpose tests, hybrid rules? | A perfectly priced interest charge can still be capped by an EBITDA-based limitation; see the debt path in [holding structures](https://wiki.private.law/en/holding-structures) |
| **Withholding and beneficial ownership** | Which source-state rate applies, and is the recipient the beneficial owner entitled to the treaty rate? | The arm's length royalty still bears [withholding tax](https://wiki.private.law/en/withholding-tax), and a conduit recipient loses the treaty rate at any price |
| **Anti-abuse (PPT/GAAR)** | Was obtaining the treaty or statutory benefit a principal purpose of the arrangement? | [The principal purpose test](https://wiki.private.law/en/gaar-ppt) attacks the entitlement, not the amount |
| **Substance** | Does the entity meet economic-presence requirements of its own state? | [Substance rules](https://wiki.private.law/en/economic-substance) sanction the entity's thinness regardless of how its transactions are priced |
| **CFC attribution** | Is the recipient's profit attributed to its controlling shareholder anyway? | An arm's length royalty flowing to a low-tax IP company can still be taxed at the parent under [CFC rules](https://wiki.private.law/en/cfc-master-guide) |
| **Permanent establishment / residence** | Does another state tax a slice (PE) or the whole (residence) of the profit? | [Corporate residence](https://wiki.private.law/en/corporate-tax-residence) and [permanent establishment](https://wiki.private.law/en/permanent-establishment) allocate taxing rights over the profit; pricing only measures it |

The table is the article's most practical content: in real disputes the taxpayer wins the pricing argument and loses the case on one of the other rows — a benchmarked management fee disallowed because the service was never evidenced, an arm's length royalty denied treaty relief because the IP company was not the beneficial owner. Reading a transfer pricing study as a general clearance is the standing category error of group tax work.

One row of that table carries a second arm's length exercise rather than a different question. Article 9 prices transactions between two separate legal persons. Article 7 attributes profit *inside* one legal person to its [permanent establishment](https://wiki.private.law/en/permanent-establishment), and under the authorised OECD approach ([2010 Report on the Attribution of Profits to Permanent Establishments](https://www.oecd.org/en/publications/2010-report-on-the-attribution-of-profits-to-permanent-establishments_2f94c049-en.html)) the branch is first hypothesised as a separate and independent enterprise: assets and risks follow the significant people functions actually performed there, "free" capital is attributed to support them, and the resulting internal *dealings* are then priced by analogy with the Guidelines — with no contract anywhere, because a company cannot contract with itself. Two consequences are practical. A group can win the Article 9 argument on its subsidiaries and still lose profit to a PE attribution in the same state. And the evidence that defends a branch is the record of what people did there, not the intercompany agreement that defends a subsidiary.

---

## Shareholder Loans: Risk, Rating and Implicit Support

Intra-group debt is the highest-volume battlefield because every parameter of a loan is a pricing lever: amount, term, currency, seniority, security, covenants, fixed or floating. The OECD's financial-transactions guidance (Guidelines Chapter X) structures the analysis in two stages: first delineate — would an independent lender have advanced this amount to this borrower on these terms, and is the instrument in substance debt? — then price, by building the borrower's credit standing and finding comparable lending.

The borrower's credit standing is where groups most often go wrong in their own favour. The rating that matters is not the group's rating, and not the subsidiary's rating as an imaginary orphan: it is the subsidiary's standing **including implicit support** — the market's expectation that the group would not let a strategically important member fail. Implicit support is *passive association*: it improves the borrower's terms, it lowers the arm's length rate, and it is not a service anyone in the group can charge for. Only an explicit, legally binding guarantee is a potentially compensable transaction of its own.

Cash pooling applies the same discipline to balances rather than to a term loan (Guidelines Chapter X, Section C.2). A pool leader that only nets balances and passes instructions performs a coordination service and earns a service reward; it keeps the spread between debit and credit rates only so far as it actually controls the risks and could bear them, and the synergy the pool creates belongs to the participants that generate it. A "short-term" pool position that never reverses is delineated for what it is — a longer-term loan, priced as one.

> ⚠️ [*Chevron Australia Holdings Pty Ltd v Commissioner of Taxation*](https://www.ato.gov.au/law/view/pdf/misc-case/rdr_2017fcafc62.pdf)[ \[2017\] FCAFC 62](https://www.ato.gov.au/law/view/pdf/misc-case/rdr_2017fcafc62.pdf) (Full Federal Court, 21 April 2017; Allsop CJ, Perram and Pagone JJ) is the reference case. An Australian subsidiary drew A$2.5 billion of facility from a US group financing company at around 9% — no security, no financial or operational covenants, no parent guarantee — while that group entity funded itself in the US commercial paper market at around 1.2%. The Full Federal Court dismissed the taxpayer's appeal under Division 13 ITAA 1936 and Subdivision 815-A ITAA 1997: the arm's length borrowing was not that of a company "shorn of all affiliation to its parent," and a borrower with Chevron's group standing — realistically with a parent guarantee — could not have obtained, and would not have agreed to, those terms. The pricing of the actual, covenant-free orphan loan was replaced by the pricing of the loan an arm's length borrower in Chevron Australia's position would have taken.

**Scenario — the same loan at two risk profiles** (fictional teaching inputs, no market rates asserted). ParentCo lends OpCo 10,000,000 for seven years in both versions. In version A, OpCo is profitable and core to the group, the loan is senior, carries market-standard covenants, and group support is realistic: the analysis rates OpCo close to the group's own standing, and the comparable search targets senior corporate lending at that rating — a relatively low margin. In version B, the same amount is subordinated to OpCo's bank debt, has no covenants, OpCo is loss-making and highly leveraged, and there is documented evidence the group would not support it: the rating is built standalone, the subordination and leverage push it further down, and the search targets junior lending to weak credits — a materially higher margin, if the delineation stage concludes an independent lender would have advanced the full amount at all. The teaching point: the *same cash movement* prices differently because risk, seniority and support differ — and each pricing conclusion stands only on an actual comparables study, which is why no figures are offered here. Whether the interest survives the payer's deduction caps is then a separate test (see the matrix above).

## IP and Royalties: Legal Ownership Against DEMPE

For intangibles the Guidelines (Chapter VI) split what groups habitually merge: **legal ownership** of the IP and **entitlement to the IP's returns**. The return follows the entities that perform and control the **DEMPE** functions — development, enhancement, maintenance, protection, exploitation — using assets and assuming the economically significant risks. A legal owner that performs none of these and merely provided the money is entitled, at most, to a financing return — and if it does not even control the financial risk of its funding, to no more than a risk-free return on it.

**Scenario — the IP-owning entity with functions elsewhere** (fictional). IPCo in State I holds the group's patents, registered in its name, and has funded development at 3,000,000 per year. Every researcher, every decision on what to develop, whether to litigate infringers and how to license sits with ParentCo's people in State R; IPCo has a single director who signs what is prepared for him. Under DEMPE the intangible returns are allocated to ParentCo: the royalties OpCos pay to IPCo are re-examined, and IPCo's retainable income shrinks toward a return on funding — risk-free if the director's signature is the only "control" of the financial risk. Note what the analysis did *not* do: it did not void IPCo's ownership, did not itself impose withholding, did not test beneficial ownership of the royalty stream — those follow their own rules. It reallocated the profit that the pricing of the royalties had placed on the legal owner.

The structural lesson runs in both directions. A group that wants the IP return in a particular entity must put the DEMPE people and the risk-control capacity there — which is an organisational decision with payroll, management and [substance](https://wiki.private.law/en/economic-substance) consequences, not a drafting decision. And a group whose functions genuinely are distributed can defend a split of the return — with a profit split method and evidence of who contributes what.

## Management Services: Evidence Before Price

For intra-group services the first question is not the mark-up but whether a chargeable service exists at all. The **benefit test** (Guidelines para 7.6): an activity is an intra-group service only if it gives the recipient economic or commercial value — measured by whether an independent enterprise in comparable circumstances would have paid another party for it or performed it in-house. Three categories fail by design: **shareholder activities** (work the parent does in its capacity as owner — consolidated reporting, its own audit, financing its own participations) are not services to the subsidiary at all; **duplication** of what the recipient already does itself; and incidental benefits of simply belonging to the group, which is passive association again.

Then comes execution evidence. A service that was genuinely rendered leaves traces: agreements dated before performance, named people, time or cost records, deliverables, correspondence, an allocation key that can be recomputed. In audits worldwide the management fee fails on this layer far more often than on price — the deduction is denied not because 5% should have been 3%, but because nothing shows the service happened or benefited the payer.

> 💡 Scenario — a fee without evidence (fictional). HoldCo charges OpCo a "management and strategic support fee" of 500,000 per year, set as a flat percentage of OpCo's turnover. On audit, OpCo can produce the invoice and a one-page agreement signed in December of the charged year; no scopes of work, no named personnel, no time records, no deliverables. The examiner never reaches method selection: the charge fails the benefit and execution layer, the deduction is denied in full, and — depending on the payer's domestic law — the payment may be recharacterised as a distribution, with [withholding](https://wiki.private.law/en/withholding-tax) consequences the fee never had. A benchmarking study proving that 500,000 is a market price for management services would have changed nothing, because price was never the failing test.

For genuinely routine support there is a deliberate shortcut. The OECD's **low value-adding intra-group services** regime (Guidelines paras 7.43–7.65) covers supportive services outside the group's core business that use no unique intangibles and assume no significant risk — typical HR, accounting, IT support. For these the simplified approach applies a fixed **5% mark-up on the relevant cost pool**, and para 7.61 states expressly that this mark-up "does not need to be justified by a benchmarking study" (TPG 7.61). The relief is narrow: the benefit test and cost documentation still apply, the cost pool must exclude pass-through costs, and states adopt the safe harbour with local variations. The US takes its own route to the same idea: the services cost method ([Treas. Reg. §1.482-9(b)](https://www.ecfr.gov/current/title-26/section-1.482-9)) allows eligible low-margin support services to be charged at cost with no mark-up at all, under its own conditions.

## After the Adjustment: Where the Cash Sits, and How Long You Have

A primary adjustment changes a tax base. It does not move money, and that gap is a problem of its own. The subsidiary has been taxed as if it had paid 5% while the group actually paid 9%, so an amount equal to the adjustment is sitting in the wrong company. States answer with a **secondary adjustment**, recharacterising that stranded amount as something taxable in its own right — commonly a constructive dividend or a deemed loan — with withholding consequences layered on top of the primary adjustment.

Where a repatriation route exists, it works on its own terms. In the US, [Rev. Proc. 99-32](https://www.irs.gov/pub/irs-drop/rp-99-32.pdf) lets the taxpayer establish an interest-bearing account receivable from, or payable to, the related person in the amount of the primary adjustment, deemed created on the last day of the adjusted year and bearing interest at an arm's length rate; where the account is paid within the 90-day window following the closing agreement or the return, the repatriating distribution ceases to be a dividend for federal income tax purposes. The cash comes home without the deemed-dividend layer — but only through the procedure, and only on time.

The taxpayer's own room to correct is asymmetric. Under [Treas. Reg. §1.482-1(a)(3)](https://www.ecfr.gov/current/title-26/section-1.482-1) a controlled taxpayer may report an arm's length result on a *timely filed* return even where it charged something different, but no untimely or amended return may be used to *decrease* taxable income on the strength of a §482 allocation. Year-end true-ups therefore run one way in the US, and a group that finds its own error after filing has lost the self-help route in that state while keeping it in the other.

The clock on relief is a treaty clock, not a domestic one. A mutual agreement procedure case must be presented within three years of the first notification of the action that results, or is likely to result, in taxation contrary to the convention, and the UK sets no requirement to exhaust domestic appeals first ([HMRC Statement of Practice 1 (2018)](https://www.gov.uk/government/publications/statement-of-practice-1-2018/statement-of-practice-1-2018)). Miss that window and a well-argued case can be left with no bilateral route at all.

## APA and MAP: The Route When Two States Disagree

A transfer pricing adjustment in one state creates economic double taxation until the other state yields. Nothing in the system makes it yield automatically. Article 9(2) of the OECD Model directs the other state to make a **corresponding adjustment** — but only where it *considers the primary adjustment justified in principle and in amount*, and the article sends disagreement to consultation between the competent authorities. The instrument for that consultation is the **mutual agreement procedure** (MAP) under Article 25, and the treaty obligation there is to *endeavour* to resolve the case, not to resolve it; a MAP can close with double taxation intact unless the applicable treaty adds mandatory binding arbitration (as some do through the MLI's arbitration part or, within the EU, the tax dispute resolution directive). The mechanics of running a MAP, its interaction with domestic appeals and its time limits are the subject of [the tax disputes article](https://wiki.private.law/en/tax-disputes).

The forward-looking route is the **advance pricing agreement** (APA): an agreement fixing, before the returns are filed, the method and conditions for defined transactions over a defined term. In the UK the statutory basis is [TIOPA 2010 ss.218–230](https://www.gov.uk/government/publications/statement-of-practice-2-2010/statement-of-practice-2-2010), administered under Statement of Practice 2 (2010), in a programme HMRC has run since 1999 for complex pricing issues; in the US the route is the APMA programme under [Rev. Proc. 2015-41](https://www.irs.gov/pub/irs-drop/rp-15-41.pdf), with MAP requests governed by the parallel Rev. Proc. 2015-40. An APA's protection is exactly as wide as its terms: it covers the transactions it names, for the years it names, on the **critical assumptions** it states — a business restructuring that breaks an assumption suspends the protection. A *bilateral* APA, agreed between two competent authorities, is the strongest instrument in the field because it commits both states to one answer in advance; a unilateral APA binds only the state that gave it and leaves the other side free to adjust.

> 🍓 The honest summary of the relief architecture: prevention (bilateral APA) is categorically stronger than cure (MAP after adjustment), and neither is automatic. A group pricing a large recurring flow — a shareholder loan, a royalty stream — is choosing, implicitly, between paying for certainty in advance and litigating ambiguity later in two states at once.

## Transaction Matrix

The matrix condenses the article: for each common controlled transaction, the delineation question that decides the analysis, the usual starting method, and the evidence that actually carries the case.

| Transaction | Delineation question | Usual starting method | Evidence that decides | Typical failure |
| --- | --- | --- | --- | --- |
| **Sale of goods** | Which party bears market and inventory risk? | CUP if true comparables exist; otherwise TNMM on the routine side | Comparables search; functional interviews | Distributor with local intangibles priced as routine |
| **Shareholder / intra-group loan** | Would an independent lender advance this amount to this borrower on these terms? | CUP against external lending at the delineated rating | Borrower rating incl. implicit support; terms vs conduct | Orphan-rating the borrower; ignoring subordination and quantum |
| **Financial guarantee** | Explicit legal commitment, or mere passive association? | Yield-differential or CUP on guarantee fees | The guarantee instrument itself; benefit beyond implicit support | Charging for comfort the market already priced in |
| **Licence / royalty** | Who performs and controls DEMPE? | CUP against genuine external licences; profit split where contributions are shared | R&D payroll and decision records by entity | Legal owner without functions keeping the residual |
| **Contract R&D** | Does the contractor control any development risk? | Cost plus / TNMM on the contractor | Who directs the programme and absorbs failure | "Contractor" that in fact owns the outcome |
| **Management / HQ services** | Is there a service at all — benefit test, shareholder-activity screen? | Cost plus / TNMM; LVAS 5% where eligible | Execution evidence: people, time, deliverables, allocation key | Fee as turnover percentage with no performance record |
| **Low value-adding support** | Supportive, non-core, no unique intangibles, no significant risk? | Simplified approach: 5% on the cost pool | Cost pool composition; pass-through exclusion; benefit documentation | Core functions smuggled into the "low value" pool |

Read column two before column three in every row: the delineation question is decided on facts that exist before any benchmark is bought, which is why the cheapest moment to fix a transfer pricing problem is when the transaction is structured, not when it is documented.

## Q/A

### How the test works

### Loans, IP and services

### **Can the tax authority treat part of our shareholder loan as equity?**

The delineation stage examines whether an independent lender would have advanced that amount to that borrower at all — quantum, not just rate. Where domestic law implements this, the excess can be denied debt treatment for pricing purposes, and separate interest-limitation and thin-capitalisation rules can cap the deduction even for correctly priced debt. Rate, quantum and deductibility are three different cuts at the same instrument.

### **Do we have to pay the parent for its guarantee of our bank debt?**

Split the two objects. An explicit, legally binding guarantee that improves your terms beyond what group membership already gives you is a service that can — and at arm's length would — carry a fee. Implicit support, the market's mere expectation that the group stands behind you, is passive association: it lowers your arm's length borrowing rate and nobody may charge for it.

### **Our IP company legally owns the patents. Why is its royalty income being reallocated?**

Because legal ownership alone carries no entitlement to the intangible's return under the DEMPE analysis. The return follows the entities whose people perform and control development, enhancement, maintenance, protection and exploitation and who bear the real risks. A legal owner that only funded the work earns a financing return at most — risk-free if it did not even control the funding risk. Moving the return requires moving functions and risk control, which is an organisational project, not a re-papering.

### **The group charges us a head-office fee under a global allocation key. Is that deductible?**

An allocation key is a legitimate charging mechanism — the low value-adding services regime is built on one — but it answers "how much," not "whether." The charge must first pass the benefit test (would an independent company have paid for this?), exclude shareholder activities and duplication, and be supported by execution evidence. A recomputable key applied to a documented cost pool for evidenced services is deductible in principle; the same key applied to an unevidenced bundle is not.

### Dispute and protection

### **If one state adjusts us, is the double taxation fixed automatically?**

No. The counterpart state reduces its tax only through a corresponding adjustment it agrees with, or through a mutual agreement procedure in which the treaty obliges the authorities to endeavour to agree — not to succeed. Mandatory binding arbitration exists only where the applicable treaty or the EU dispute-resolution framework provides it. Until one of those routes concludes, both assessments stand.

### **Does an APA make us audit-proof?**

Only within its four corners: the named transactions, the agreed method, the covered years and the critical assumptions. Break an assumption — a restructuring, a changed functional profile — and the protection lapses. A unilateral APA binds one state only; the counterparty state can still adjust, which is why bilateral APAs are the instrument of choice for large recurring flows despite the longer negotiation.

### **Our transfer pricing study is clean. Can the deduction still be denied?**

Yes, and this is the single most practical thing to understand about the field. Pricing is one test among several that run on the same payment: interest-limitation caps, withholding and beneficial ownership at source, principal-purpose and general anti-abuse rules, substance requirements at the recipient, CFC attribution at the shareholder. A clean study answers only the pricing question; every other row of the table in this article keeps its own life.

### **The adjustment is agreed, but the money is still in the wrong company. What happens to it?**

That is the secondary adjustment problem. The primary adjustment moves a tax base, not cash, so the state can recharacterise the stranded amount — commonly as a constructive dividend or a deemed loan — with its own withholding consequences. Where a repatriation route exists it must be used on its terms: in the US, Rev. Proc. 99-32 allows an interest-bearing account receivable or payable equal to the primary adjustment, settled within the 90-day window, so that the repatriating distribution is not treated as a dividend. Fixing the tax number and leaving the cash where it is invites the second charge.

---

## Factual claims

- Cash pooling applies the same discipline to balances rather than to a term loan (Guidelines Chapter X, Section C.2).
- The matrix condenses the article: for each common controlled transaction, the delineation question that decides the analysis, the usual starting method, and the evidence that actually carries the case.

---

Source: wiki.private.law — the private.law legal knowledge base. When quoting, cite the canonical page URL.
Consultation with a lawyer: https://t.me/private_law_bot